71 / 82
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 1, January/February 2018
AFRICA
e5
2.
Maron BJ. Hypertrophic cardiomyopathy: a systematic review.
J Am
Med Assoc
2002;
287
: 1308–1320.
3.
Hagege A. Cardiomyopathie hypertrophique. In: Cohen A, Gueret P
(eds).
Manuel d’échocardiographie clinique
. Paris: Lavoisier Médecine
Sciences, 2012: 331–345.
4.
Spirito P, Chiarella F, Carratino L, Berisso MZ, Belloti P, Vecchio C.
Clinical course and prognosis of hypertrophic cardiomyopathy in an
outpatient population.
N Engl J Med
1989;
320
: 749–755.
5.
Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardi-
omyopathy: a profile of 78 patients.
Circulation
1982;
65
: 1388–1394.
6.
Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE,
et al.
Epidemiology of hypertrophic cardiomyopathy-related death: revisited
in a large non referral-based patient population.
Circulation
2000;
102
:
858–864.
7.
European Society of Cardiology
.
HCM risk-SCD calculator [en ligne].
Consulté le 09 Octobre 2016. Disponible sur
http://www.doc2do.com/hcm/webHCM.html.
8.
Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna
WJ. Relation between severity of left-ventricular hypertrophy and
prognosis in patients with hypertrophic cardiomyopathy.
Lancet
2001;
357
: 420–424.
9.
Maki S, Ikeda H, Muro A, Yoshida N, Shibata A, Koga Y,
et al.
Predictors of sudden cardiac death in hypertrophic cardiomyopathy.
Am
J Cardiol
1998;
82
: 774–778.
10. Niamkey T, Anzouan-Kacou JB, Coulibaly I, N’Guetta AR, N’Cho-
Mottoh MP, Gnamba A,
et al.
Evaluation des facteurs majeurs de
mort subite chez les porteurs de CMH primitive.
Cardiol Trop
2013;
134
: 15–16.
11. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of
distribution of left ventricular hypertrophy in hypertrophic cardiomyo-
pathy: a wide-angle, two-dimensional echocardiographic study of 125
patients.
Am J Cardiol
1981;
48
: 418–428.
12. Charron P, Komajda M. Cardiomyopathie hypertrophique.
EMC
Cardiologie Angéiologie
2005;
2
: 103–119.
13. Elliott P, McKenna WJ.
Hypertrophic cardiomyopathy.
Lancet
2004;
363
: 1881–1891.
14. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ,
Seidman CE,
et al.
American College of Cardiology/European Society
of Cardiology: Clinical expert consensus document on hypertrophic
cardiomyopathy.
Eur Heart J
2003;
24
: 1965–1991.
15. Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardio-
myopathy.
Circulation
1992;
85
: 157–163.
16. Mc Kenna WJ, Franklin RC, Nihoyannopoulos P, Robinson KC,
Deanfield JE. Arrhythmia and prognosis in infants, children and
adolescents with hypertrophic cardiomyopathy.
J Am Coll Cardiol
1988;
11
: 147–153.
17. Cannan CR, Reeder GS, Bailey KR, Melton LJ, Gersh BJ.
Natural
history of hypertrophic cardiomyopathy: a population based study, 1976
through 1990.
Circulation
1995;
92
: 2488–2495.
18. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ.
Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome
in an unselected regional population.
J Am Coll Cardiol
1995;
26
:
1529–1536.
19. Kofflard MJ, Waldstein DJ, Vos J, Ten Cate FJ
.
Prognosis in hyper-
trophic cardiomyopathy observed in a large clinic population.
Am J
Cardiol
1993;
72
: 939–943.
20. Dubourg O, Mansencal N, Charron P. Recommendations for the diag-
nosis and management of hypertrophic cardiomyopathy in 2014.
Arch
Cardiovasc Dis
2015;
108
: 151–155.
21. Ho CY, Seidman CE. A contemporary approach to hypertrophic cardio-
myopathy.
Circulation
2006;
113
: 858–862.
22. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of
hypertrophic cardiomyopathy.
N Engl J Med
1997;
336
: 775–785.
23. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F,
Charron P,
et al.
2014 ESC guidelines on diagnosis and management of
hypertrophic cardiomyopathy.
Eur Heart J
2014;
35
: 2733–2779.